FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113402100> ?p ?o ?g. }

• W2113402100 abstract "Berylliosis or Chronic Beryllium Disease is a chronic granulomatous disorder primarily involving the lung associated with the exposition to low doses of Beryllium (Be) in the workplace. Berylliosis risk has been associated with the presence of a glutamate at position 69 of the HLA-DP beta chain (HLA-DPbetaGlu69) that is expressed in about 97% of disease cases and in 27% of the unaffected Be-exposed controls (p<0.0001) (Richeldi et al. Science 1993; 262: 242-244.12). Since this first observation of an immunogenetic association between berylliosis and HLA-DPbetaGlu69 a number of studies have confirmed the role of this marker as the primary gene of susceptibility of berylliosis (Richeldi et al Am J Ind Med. 1997; 32:337-40; Wang et al J. Immunol. 1999; 163: 1647-53; Saltini et al Eur Respir J. 2001 18:677-84; Rossman et al Am J Respir Crit Care Med. 2002 165:788-94). Moreover, a structure/function interaction between HLA-DP molecules carrying Glu69 and beryllium in driving and developing the immune response against beryllium itself has been observed as: (1) Be-specific T-cells clones obtained from berylliosis patients recognize beryllium as antigen only when presented in the context of the HLA-DP{beta}Glu69 molecules but not in the context of HLA-DP allelic variants carrying Lys69 (Lombardi G etmore » al. J Immunol 2001; 166: 3549-3555), and (2) beryllium presents an affinity for the HLA-DP2, carrying the berylliosis marker of susceptibility HLA-DPGlu69, from 40 to 100 times higher that the HLA-DP molecule carrying Lys69 (Amicosante M. et al Hum. Immunol. 2001; 62: 686-93). However, although the immunogenetic studies performed have been addressed a number of different questions about the genetic association between berylliosis and/or beryllium sensitization, exposure levels to beryllium and HLA markers, a number of questions are still open in the field mainly due to the limitation imposed by the low number of subjects carrying berylliosis or beryllium sensitization enrolled in each immunogenetic study. In this context, the populations of the study already performed in this field by the University of Modena and Rome (by Prof. C. Saltini) and the University of Pennsylvania (by Prof. M. Rossman) have been evaluated by using similar HLA molecular typing methodologies and that both populations have now been followed up for a period of 4 to 7 years. The general objective of this study has to generate a larger data base comprising the two population with which analyze gene disease association with greater statistical power and ascertain the effect of lesser common gener variants which may be missed when analyzing associations on small populations. In particular addressing the role suggested in previous study such as: (1) the role of HLA-DP rare alleles and polymorphisms, and (2) the role of the HLA markers in disease progression from sensitization. The two populations from the already published studies (Saltini et al Eur Respir J. 2001 18:677-84; Rossman et al Am J Respir Crit Care Med. 2002 165:788-94) present similar aspects about: ethnicity, type and length of exposure to Be dust, a broadly similar association between beryllium related abnormalities and HLA. The two population have been pooled and evaluated using common criteria of diagnosis (Sensitized subject: at least 2 positive BeLPT tests each with 2 positive wells; CBD-affected subject: identification of well formed non-caseating granulomas on biopsy), follow up and HLA typing technique (complete HLA-DRB, DQB, DPB high resolution typing using amplification with sequence specific primers or sequence based typing). The two populations included 137 subjects with Beryllium hypersensitized (BH) and 155 Be-exposed controls. Inclusion criteria were met by one hundred and six subjects with Be-hypersensitivity of whom 55 were affected by CBD (age 52 {+-} 11 years; 50 caucasians, 2 African-Americans 2 Hispanics and 1 Asian; 46 males and 9 females; mean duration of Be-exposure 15 {+-} 9 years) and 51 showed Be-sensitization without lung granulomas detected by trans-bronchial biopsy (age 54 {+-} 14 years; 47 Caucasians, 3 Hispanics and 1 Afro-American; 45 males and 6 females; mean age of Be-exposure 17 {+-} 10 years) and 129 Be-exposed controls (age 53 {+-} 14 years; 120 Caucasians, 4 African-American, 4 Hispanics, 1 Asian; 104 males and 25 females; mean duration of Be-exposure 16 {+-} 10 years). Mean follow-up of BH affected subjects was 7.0 {+-} 3.7 years from the first positive Be-LPT test.« less" @default.
• W2113402100 created "2016-06-24" @default.
• W2113402100 creator A5032263266 @default.
• W2113402100 creator A5043696677 @default.
• W2113402100 date "2009-12-19" @default.
• W2113402100 modified "2023-10-17" @default.
• W2113402100 title "Analysis of HLA-DP association with beryllium disease susceptibility in pooled exposed populations" @default.
• W2113402100 doi "https://doi.org/10.2172/969219" @default.
• W2113402100 hasPublicationYear "2009" @default.
• W2113402100 type Work @default.
• W2113402100 sameAs 2113402100 @default.
• W2113402100 citedByCount "0" @default.
• W2113402100 crossrefType "report" @default.
• W2113402100 hasAuthorship W2113402100A5032263266 @default.
• W2113402100 hasAuthorship W2113402100A5043696677 @default.
• W2113402100 hasBestOaLocation W21134021001 @default.
• W2113402100 hasConcept C142853389 @default.
• W2113402100 hasConcept C147483822 @default.
• W2113402100 hasConcept C15744967 @default.
• W2113402100 hasConcept C178790620 @default.
• W2113402100 hasConcept C185592680 @default.
• W2113402100 hasConcept C188280979 @default.
• W2113402100 hasConcept C506630978 @default.
• W2113402100 hasConcept C542102704 @default.
• W2113402100 hasConcept C54355233 @default.
• W2113402100 hasConcept C71924100 @default.
• W2113402100 hasConcept C86803240 @default.
• W2113402100 hasConceptScore W2113402100C142853389 @default.
• W2113402100 hasConceptScore W2113402100C147483822 @default.
• W2113402100 hasConceptScore W2113402100C15744967 @default.
• W2113402100 hasConceptScore W2113402100C178790620 @default.
• W2113402100 hasConceptScore W2113402100C185592680 @default.
• W2113402100 hasConceptScore W2113402100C188280979 @default.
• W2113402100 hasConceptScore W2113402100C506630978 @default.
• W2113402100 hasConceptScore W2113402100C542102704 @default.
• W2113402100 hasConceptScore W2113402100C54355233 @default.
• W2113402100 hasConceptScore W2113402100C71924100 @default.
• W2113402100 hasConceptScore W2113402100C86803240 @default.
• W2113402100 hasLocation W21134021001 @default.
• W2113402100 hasLocation W21134021002 @default.
• W2113402100 hasLocation W21134021003 @default.
• W2113402100 hasOpenAccess W2113402100 @default.
• W2113402100 hasPrimaryLocation W21134021001 @default.
• W2113402100 hasRelatedWork W1828691184 @default.
• W2113402100 hasRelatedWork W1920751942 @default.
• W2113402100 hasRelatedWork W1991523530 @default.
• W2113402100 hasRelatedWork W2002128513 @default.
• W2113402100 hasRelatedWork W2020824267 @default.
• W2113402100 hasRelatedWork W2031436818 @default.
• W2113402100 hasRelatedWork W2057739827 @default.
• W2113402100 hasRelatedWork W2075354549 @default.
• W2113402100 hasRelatedWork W2119103177 @default.
• W2113402100 hasRelatedWork W2092874662 @default.
• W2113402100 isParatext "false" @default.
• W2113402100 isRetracted "false" @default.
• W2113402100 magId "2113402100" @default.
• W2113402100 workType "report" @default.